cilostazol has been researched along with Cognition Disorders in 7 studies
Cognition Disorders: Disorders characterized by disturbances in mental processes related to learning, thinking, reasoning, and judgment.
| Excerpt | Relevance | Reference |
|---|---|---|
| " This PICASSO-COG (PreventIon of CArdiovascular events in iSchemic Stroke patients with high risk of cerebral hemOrrhage for reducing COGnitive decline) substudy aims to assess the effects of cilostazol and/or probucol on cognitive function." | 5.22 | Design and Rationale for a Cognitive Outcome Substudy in Ischemic Stroke Patients with High Risk of Cerebral Hemorrhage. ( Hong, KS; Kwon, SU; Lee, J; Lee, JS; Oh, MS; Yu, KH, 2016) |
| "Cilostazol(CTL) is a phosphodiesterase inhibitor, which has been widely used as anti-platelet agent." | 1.43 | Neuroprotection of Cilostazol against ischemia/reperfusion-induced cognitive deficits through inhibiting JNK3/caspase-3 by enhancing Akt1. ( Li, M; Liu, F; Liu, P; Ma, JY; Mei, XY; Miu, JC; Qi, DS; Qu, R; Tao, JH; Wang, M; Zhang, F; Zhang, LQ; Zhang, SC, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 6 (85.71) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blair, GW | 1 |
| Appleton, JP | 1 |
| Law, ZK | 1 |
| Doubal, F | 1 |
| Flaherty, K | 1 |
| Dooley, R | 1 |
| Shuler, K | 1 |
| Richardson, C | 1 |
| Hamilton, I | 1 |
| Shi, Y | 1 |
| Stringer, M | 1 |
| Boyd, J | 1 |
| Thrippleton, MJ | 1 |
| Sprigg, N | 1 |
| Bath, PM | 1 |
| Wardlaw, JM | 1 |
| Kwon, KJ | 1 |
| Lee, EJ | 1 |
| Kim, MK | 1 |
| Kim, SY | 1 |
| Kim, JN | 1 |
| Kim, JO | 1 |
| Kim, HJ | 1 |
| Kim, HY | 1 |
| Han, JS | 1 |
| Shin, CY | 1 |
| Han, SH | 1 |
| Yu, KH | 1 |
| Hong, KS | 1 |
| Oh, MS | 1 |
| Lee, J | 1 |
| Lee, JS | 1 |
| Kwon, SU | 1 |
| Qi, DS | 1 |
| Tao, JH | 1 |
| Zhang, LQ | 1 |
| Li, M | 1 |
| Wang, M | 1 |
| Qu, R | 1 |
| Zhang, SC | 1 |
| Liu, P | 1 |
| Liu, F | 1 |
| Miu, JC | 1 |
| Ma, JY | 1 |
| Mei, XY | 1 |
| Zhang, F | 1 |
| Park, SH | 1 |
| Kim, JH | 1 |
| Bae, SS | 1 |
| Hong, KW | 2 |
| Lee, DS | 1 |
| Leem, JY | 1 |
| Choi, BT | 1 |
| Shin, HK | 1 |
| Shirayama, Y | 1 |
| Konishi, T | 1 |
| Hashimoto, K | 1 |
| Lee, JH | 1 |
| Park, SY | 1 |
| Shin, YW | 1 |
| Kim, CD | 1 |
| Lee, WS | 1 |
3 trials available for cilostazol and Cognition Disorders
| Article | Year |
|---|---|
Preventing cognitive decline and dementia from cerebral small vessel disease: The LACI-1 Trial. Protocol and statistical analysis plan of a phase IIa dose escalation trial testing tolerability, safety and effect on intermediary endpoints of isosorbide mon
Topics: Age Factors; Cerebral Small Vessel Diseases; Cilostazol; Cognition Disorders; Dementia; Double-Blind | 2018 |
Design and Rationale for a Cognitive Outcome Substudy in Ischemic Stroke Patients with High Risk of Cerebral Hemorrhage.
Topics: Adult; Anticholesteremic Agents; Brain Ischemia; Cerebral Hemorrhage; Cilostazol; Cognition Disorder | 2016 |
Effects of add-on cilostazol on cognition in patients with schizophrenia: an open-label pilot trial.
Topics: Adult; Antipsychotic Agents; Cilostazol; Cognition Disorders; Drug Therapy, Combination; Humans; Pho | 2011 |
4 other studies available for cilostazol and Cognition Disorders
| Article | Year |
|---|---|
Diabetes augments cognitive dysfunction in chronic cerebral hypoperfusion by increasing neuronal cell death: implication of cilostazol for diabetes mellitus-induced dementia.
Topics: Animals; Brain; Brain-Derived Neurotrophic Factor; Carotid Artery Diseases; Caspase 3; Cell Death; C | 2015 |
Neuroprotection of Cilostazol against ischemia/reperfusion-induced cognitive deficits through inhibiting JNK3/caspase-3 by enhancing Akt1.
Topics: Animals; Apoptosis; Brain Ischemia; Caspase 3; Cilostazol; Cognition Disorders; Disease Models, Anim | 2016 |
Protective effect of the phosphodiesterase III inhibitor cilostazol on amyloid β-induced cognitive deficits associated with decreased amyloid β accumulation.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Cell Line, Tumor; Cilostazol; Cognition Disorders | 2011 |
Concurrent administration of cilostazol with donepezil effectively improves cognitive dysfunction with increased neuroprotection after chronic cerebral hypoperfusion in rats.
Topics: Animals; Behavior, Animal; Brain; Brain Ischemia; Choline O-Acetyltransferase; Cilostazol; Cognition | 2007 |